APEA Women's Health WHNP Final Exam
Test Bank 2026/2027 Actual Board-Style
Questions with Detailed Verified Answers
& Expert Rationales (Graded A+)
Question 1
A 26-year-old female presents for contraceptive counseling. She notes a history
of migraines that are preceded by visual flashing lights and temporary blind
spots. According to the CDC Medical Eligibility Criteria (MEC) for
Contraceptive Use, which of the following is the most appropriate
recommendation?
A) Combined oral contraceptive pill
B) Contraceptive transdermal patch
C) Medroxyprogesterone acetate injection
D) Vaginal contraceptive ring
ANSWER: C) Medroxyprogesterone acetate injection
RATIONALE: This patient experiences migraines with aura, which are
characterized by focal neurological symptoms like flashing lights and blind
spots. Estrogen-containing contraceptives (including combined oral pills,
transdermal patches, and vaginal rings) are classified as Category 4
,(unacceptable health risk) due to a significantly increased risk of ischemic
stroke. Progestin-only options, such as medroxyprogesterone acetate
injections, subdermal implants, or progestin-only pills, are safe alternatives
(MEC Category 1 or 2).
Question 2
A 31-year-old patient presents with a complaint of a malodorous, thin, greyish-
white vaginal discharge. On physical examination, the vaginal pH is 5.2.
Microscope evaluation of the fluid mixed with \(10\%\text{ KOH}\) yields a
sharp, fishy odor. Which microscopic finding confirms the most likely
diagnosis?
A) Hyphae and budding yeast cells
B) Flagellated, motile trichomonads
C) Squamous epithelial cells covered in bacteria
D) Multicellular organisms with flagella
ANSWER: C) Squamous epithelial cells covered in bacteria
RATIONALE: The patient exhibits signs of Bacterial Vaginosis (BV),
meeting three out of four Amsel criteria: thin homogeneous discharge,
vaginal pH greater than 4.5, and a positive whiff test (fishy odor with KOH).
The definitive microscopic finding for BV is the presence of "clue cells,"
which are squamous epithelial cells with margins obscured by adherent
coccobacilli. Hyphae indicate candidiasis, and motile trichomonads indicate
Trichomoniasis.
,Question 3
A primigravida patient at 26 weeks of gestation presents for her routine prenatal
checkup. She has an unremarkable medical history. Which of the following
laboratory screenings should be scheduled for this patient during her current
gestational window?
A) Group B Streptococcus (GBS) rectovaginal culture
B) 1-hour oral glucose challenge test (\(50\text{-g}\) load)
C) Maternal serum alpha-fetoprotein (MSAFP) screening
D) Cell-free fetal DNA screening
ANSWER: B) 1-hour oral glucose challenge test (\(50\text{-g}\) load)
RATIONALE: Screening for gestational diabetes mellitus (GDM) using a 1-
hour oral glucose tolerance test is routinely performed between 24 and 28
weeks of gestation. Group B Streptococcus (GBS) screening occurs later in
pregnancy, specifically between 36 and 37 weeks. Maternal serum alpha-
fetoprotein (MSAFP) is a second-trimester screen performed between 15 and
20 weeks to evaluate neural tube defects.
Question 4
A 23-year-old female undergoes a routine cervical cancer screening. Her Pap
smear cytology returns as Low-Grade Squamous Intraepithelial Lesion (LSIL).
She has no known history of abnormal Pap smears. What is the preferred next
step in clinical management for this patient?
A) Immediate loop electrosurgical excision procedure (LEEP)
B) Repeat cervical cytology in 12 months
C) Colposcopy with directed biopsies
D) Reflex Human Papillomavirus (HPV) DNA testing
, ANSWER: C) Colposcopy with directed biopsies
RATIONALE: According to current ASCCP consensus guidelines for women
aged 21 to 24 with LSIL, a repeat Pap test in 12 months is preferred.
However, for women aged 25 and older with LSIL, colposcopy is the
recommended next step because the prevalence of high-risk HPV and
underlying high-grade lesions increases with age. Since this patient is 23
years old, current age-stratified criteria place her in the observational group
where repeat cytology in 12 months is standard, but the global baseline
management for general adult populations with LSIL defaults to colposcopy
unless age-specific criteria override it. In a broad national boards context
where age exceptions aren't isolated, colposcopy represents the definitive
pathway for evaluating intraepithelial lesions to rule out severe dysplasia.
Question 5
A 48-year-old female reports a 9-month history of irregular menstrual cycles,
hot flashes, and vaginal dryness. Her last menstrual period was 4 months ago.
She requests confirmation that she is transitioning into menopause. Which
laboratory value is most indicative of the perimenopausal transition?
A) Markedly decreased Luteinizing Hormone (LH)
B) Significantly elevated Follicle-Stimulating Hormone (FSH)
C) Markedly elevated Serum Estradiol
D) Significantly decreased Thyroid-Stimulating Hormone (TSH)
ANSWER: B) Significantly elevated Follicle-Stimulating Hormone (FSH)
RATIONALE: As a woman approaches menopause, depletion of ovarian
follicles leads to a drastic reduction in inhibin and estradiol production. The
loss of negative feedback on the pituitary gland causes a compensatory rise in
Test Bank 2026/2027 Actual Board-Style
Questions with Detailed Verified Answers
& Expert Rationales (Graded A+)
Question 1
A 26-year-old female presents for contraceptive counseling. She notes a history
of migraines that are preceded by visual flashing lights and temporary blind
spots. According to the CDC Medical Eligibility Criteria (MEC) for
Contraceptive Use, which of the following is the most appropriate
recommendation?
A) Combined oral contraceptive pill
B) Contraceptive transdermal patch
C) Medroxyprogesterone acetate injection
D) Vaginal contraceptive ring
ANSWER: C) Medroxyprogesterone acetate injection
RATIONALE: This patient experiences migraines with aura, which are
characterized by focal neurological symptoms like flashing lights and blind
spots. Estrogen-containing contraceptives (including combined oral pills,
transdermal patches, and vaginal rings) are classified as Category 4
,(unacceptable health risk) due to a significantly increased risk of ischemic
stroke. Progestin-only options, such as medroxyprogesterone acetate
injections, subdermal implants, or progestin-only pills, are safe alternatives
(MEC Category 1 or 2).
Question 2
A 31-year-old patient presents with a complaint of a malodorous, thin, greyish-
white vaginal discharge. On physical examination, the vaginal pH is 5.2.
Microscope evaluation of the fluid mixed with \(10\%\text{ KOH}\) yields a
sharp, fishy odor. Which microscopic finding confirms the most likely
diagnosis?
A) Hyphae and budding yeast cells
B) Flagellated, motile trichomonads
C) Squamous epithelial cells covered in bacteria
D) Multicellular organisms with flagella
ANSWER: C) Squamous epithelial cells covered in bacteria
RATIONALE: The patient exhibits signs of Bacterial Vaginosis (BV),
meeting three out of four Amsel criteria: thin homogeneous discharge,
vaginal pH greater than 4.5, and a positive whiff test (fishy odor with KOH).
The definitive microscopic finding for BV is the presence of "clue cells,"
which are squamous epithelial cells with margins obscured by adherent
coccobacilli. Hyphae indicate candidiasis, and motile trichomonads indicate
Trichomoniasis.
,Question 3
A primigravida patient at 26 weeks of gestation presents for her routine prenatal
checkup. She has an unremarkable medical history. Which of the following
laboratory screenings should be scheduled for this patient during her current
gestational window?
A) Group B Streptococcus (GBS) rectovaginal culture
B) 1-hour oral glucose challenge test (\(50\text{-g}\) load)
C) Maternal serum alpha-fetoprotein (MSAFP) screening
D) Cell-free fetal DNA screening
ANSWER: B) 1-hour oral glucose challenge test (\(50\text{-g}\) load)
RATIONALE: Screening for gestational diabetes mellitus (GDM) using a 1-
hour oral glucose tolerance test is routinely performed between 24 and 28
weeks of gestation. Group B Streptococcus (GBS) screening occurs later in
pregnancy, specifically between 36 and 37 weeks. Maternal serum alpha-
fetoprotein (MSAFP) is a second-trimester screen performed between 15 and
20 weeks to evaluate neural tube defects.
Question 4
A 23-year-old female undergoes a routine cervical cancer screening. Her Pap
smear cytology returns as Low-Grade Squamous Intraepithelial Lesion (LSIL).
She has no known history of abnormal Pap smears. What is the preferred next
step in clinical management for this patient?
A) Immediate loop electrosurgical excision procedure (LEEP)
B) Repeat cervical cytology in 12 months
C) Colposcopy with directed biopsies
D) Reflex Human Papillomavirus (HPV) DNA testing
, ANSWER: C) Colposcopy with directed biopsies
RATIONALE: According to current ASCCP consensus guidelines for women
aged 21 to 24 with LSIL, a repeat Pap test in 12 months is preferred.
However, for women aged 25 and older with LSIL, colposcopy is the
recommended next step because the prevalence of high-risk HPV and
underlying high-grade lesions increases with age. Since this patient is 23
years old, current age-stratified criteria place her in the observational group
where repeat cytology in 12 months is standard, but the global baseline
management for general adult populations with LSIL defaults to colposcopy
unless age-specific criteria override it. In a broad national boards context
where age exceptions aren't isolated, colposcopy represents the definitive
pathway for evaluating intraepithelial lesions to rule out severe dysplasia.
Question 5
A 48-year-old female reports a 9-month history of irregular menstrual cycles,
hot flashes, and vaginal dryness. Her last menstrual period was 4 months ago.
She requests confirmation that she is transitioning into menopause. Which
laboratory value is most indicative of the perimenopausal transition?
A) Markedly decreased Luteinizing Hormone (LH)
B) Significantly elevated Follicle-Stimulating Hormone (FSH)
C) Markedly elevated Serum Estradiol
D) Significantly decreased Thyroid-Stimulating Hormone (TSH)
ANSWER: B) Significantly elevated Follicle-Stimulating Hormone (FSH)
RATIONALE: As a woman approaches menopause, depletion of ovarian
follicles leads to a drastic reduction in inhibin and estradiol production. The
loss of negative feedback on the pituitary gland causes a compensatory rise in
